rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Warby Parker Inc.

WRBY · NYSE

Health CareMedical DevicesJust dropped out

WRBY stood above a rising 150-day average in 23 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 7.4% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$86.0M
Officials’ trades on record
3
Institutions holding
288 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 23 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$31.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

3 disclosed lines: House 0, Senate 0, executive 3; 1 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k31 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k29 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k22 Jun 2026filed 22 Aug 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months31
Buyers · sellers0 · 7
WhoDidSharesTraded
Neil Harris BlumenthalCo-Chief Executive Officersold100,000at $27.691 Oct 2026filed 2 Oct 2026
Jeffrey Jacob RaiderDirectorsold15,000at $27.701 Oct 2026filed 2 Oct 2026
Neil Harris BlumenthalCo-Chief Executive Officersold9,200at $29.996 Jul 2026filed 8 Jul 2026
David Abraham GilboaCo-Chief Executive Officersold54,347at $29.846 Jul 2026filed 8 Jul 2026
Neil Harris BlumenthalCo-Chief Executive Officersold217,667at $29.611 Jul 2026filed 2 Jul 2026
David Abraham GilboaCo-Chief Executive Officersold242,221at $29.691 Jul 2026filed 2 Jul 2026
Jeffrey Jacob RaiderDirectorsold22,500at $29.721 Jul 2026filed 2 Jul 2026
Neil Harris BlumenthalCo-Chief Executive Officersold36,300at $30.0429 Jun 2026filed 1 Jul 2026
Teresa BriggsDirectorsold3,092at $25.4116 Jun 2026filed 18 Jun 2026
Teresa BriggsDirectorsold1,908at $26.7916 Jun 2026filed 18 Jun 2026
Youngme E. MoonDirectorsold10,000at $26.5312 Jun 2026filed 12 Jun 2026
Neil Harris BlumenthalCo-Chief Executive Officersold63,040at $30.0319 May 2026filed 21 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders288+2 on the quarter
New · exited65 · 63
Reported value$3.7B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 202615,577,440$472.6M+51,068+0.3%
BlackRock, Inc.added · filed 7 Aug 202615,309,616$464.5M+8,050,553+110.9%
JPMORGAN CHASE & COnew · filed 12 Aug 202611,110,949$334.7M+11,110,949
Durable Capital Partners LPunchanged · filed 14 Aug 20266,396,513$194.1M00.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20265,983,328$181.5M+651,775+12.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20264,487,337$136.1M+83,829+1.9%
STATE STREET CORPadded · filed 7 Aug 20264,184,803$127.0M+1,761,159+72.7%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.added · filed 16 Jul 20263,107,226$94.3M+78,919+2.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20262,571,338$78.0M+197,002+8.3%
FULLER & THALER ASSET MANAGEMENT, INC.added · filed 12 Aug 20262,397,130$72.7M+84,193+3.6%
31 Mar 2023 – 30 Jun 2026
134208282Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Jeffrey Jacob Raider Company insiderDirector · last 1 Oct 20260 · 9
Neil Harris Blumenthal Company insiderCo-Chief Executive Officer · last 1 Oct 20260 · 49
David Abraham Gilboa Company insiderCo-Chief Executive Officer · last 2 Sep 20260 · 45
Donald J. Trump Executive branchWhite House Office · last 31 Aug 20262 · 1
Teresa Briggs Company insiderDirector · last 16 Jun 20260 · 6
Youngme E. Moon Company insiderDirector · last 12 Jun 20260 · 4
Andrew Hunt Company insiderDirector · last 8 Jun 20260 · 0
Bradley E. Singer Company insiderDirector · last 8 Jun 20262 · 3
Ronald A. Williams Company insiderDirector · last 8 Jun 20260 · 0
Adrian Mitchell V Company insiderChief Financial Officer · last 10 Feb 20260 · 0
Joel E. Cutler Company insiderDirector · last 16 Dec 20250 · 8
Steven Clive Miller Company insiderChief Financial Officer · last 3 Sep 20251 · 33

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202554.0%
Operating profit marginFY 2025 · to 31 Dec 2025-0.6%
Free cash flow marginFY 2025 · to 31 Dec 20255.0%
Return on capital employedFY 2025 · to 31 Dec 2025-0.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$286.4M
Free cash flowFY 2025 · to 31 Dec 2025$43.7M

Analyst forecasts

No analyst forecasts yet.